Jeffrey A. Whitnell

Chief Financial Officer, Akorn.

Companies

ELITE PHARMACEUTICALS INC /NV/Board member Feb 23, 2011 to Nov 27, 2023¹
AkornChief executive officer Apr 21, 2009 to Apr 23, 2009²
AkornChief financial officer Apr 12, 2006 to Apr 23, 2009³
AkornBoard member Apr 21, 2009 to Apr 21, 2009²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

ELITE PHARMACEUTICALS INC /NV/ ELTP3,187,020 shares⁴$790.7K at $0.25Nov 22, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 22, 2023Granted 547,657 shares at $0.04 of ELITE PHARMACEUTICALS INC /NV/⁴
Aug 28, 2022Granted 459,536 shares at $0.04 of ELITE PHARMACEUTICALS INC /NV/⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARELITE PHARMACEUTICALS INC /NV/, Board member
2
SEC EDGARAkorn, Chief executive officer
3
SEC EDGARAkorn, Chief financial officer
4
SEC EDGARELITE PHARMACEUTICALS INC /NV/ shares after the filing of Nov 22, 2023
5
SEC EDGARForm 4 filed Aug 29, 2022